China Is Top International Priority For AdvaMed's New Chairman
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers
You may also be interested in...
Despite Reg Challenges, China Market Access Gradually Improving
China's regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region
Despite Reg Challenges, China Market Access Gradually Improving
China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.
Despite Reg Challenges, China Market Access Gradually Improving
China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.